Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Kirit Singh, Kelly M. Hotchkiss, Ian F. Parney, John De Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, Evanthia Galanis, Michael Lim, Patrick Y. Wen, Giuseppe Minniti, Howard Colman, Timothy F. Cloughesy, Minesh P. Mehta, Marjolein Geurts, Isabel Arrillaga-Romany, Annick Desjardins, Kirk Tanner, Susan Short, David AronsElizabeth Duke, Wolfgang Wick, Stephen J. Bagley, David M. Ashley, Priya Kumthekar, Roel Verhaak, Anthony J. Chalmers, Anoop P. Patel, Colin Watts, Peter E. Fecci, Tracy T. Batchelor, Michael Weller, Michael A. Vogelbaum, Matthias Preusser, Mitchel S. Berger, Mustafa Khasraw*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)2402-2405
Number of pages4
JournalNature Medicine
Volume29
Issue number10
DOIs
StatePublished - Oct 2023

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Cite this